AMEERA-5: a randomized, double-blind phase 3 study of amcenestrant plus palbociclib versus letrozole plus palbociclib for previously untreated ER+/HER2- advanced breast cancer.

Aditya Bardia Javier CortesSara A HurvitzSuzette DelalogeHiroji IwataZhi-Ming ShaoDheepak KanagavelPatrick CohenQianying LiuSylvaine Cartot-CottonVasiliki PelekanouJoyce O'Shaughnessy

Published in: Therapeutic advances in medical oncology (2022)

NCT04478266.

Keyphrases

double blind
placebo controlled
metastatic breast cancer
clinical trial
open label
phase iii
phase ii
study protocol
endoplasmic reticulum
estrogen receptor
early breast cancer
breast cancer cells
randomized controlled trial
metabolic syndrome
adipose tissue
skeletal muscle